Skip to content

An observational multi-center study on COVID 19 disease to study on HERD immunity

An observational multi-center study on COVID 19 disease to study on HERD immunity in the population based on random sampling through conducting at two time points to infer epidemic trajectory. - SARS-CoV2 infection Survey/2020

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/09/027881
Enrollment
1000
Registered
2020-09-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Public Health Department
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Apparently Healthy subjects will be recruited. 2.Subjects of both sexes aged more than 10 years old. 3.Willing and able to provide written informed consent 4.Subjects who has not tested positive for COVID 19 infection in the past.

Exclusion criteria

Exclusion criteria: 1.Subjects having less than 10 years of age 2.Subjects already tested positive for the COVID19 infection in the past and cured. 3.Critical co-morbidities.

Design outcomes

Primary

MeasureTime frame
Compared to the other infections, COVID infections are more asymptomatic and there is a chance to recover without any medications or standard of care for COVID-19 disease.Timepoint: 14 days

Secondary

MeasureTime frame
There will be a chance to develop the antibodies or develop the resistance against the COVID-19 can be known as HERD immunity. There will be reduction in spreading of the COVID infection through developing the immunity and wearing masks and taking all the precautions as per the WHO guidelines.Timepoint: 14 days

Countries

India

Contacts

Public ContactDr Dhananjay Lad

CROM Clinical Research & Medical Tourism Pvt. Ltd.

laddhl@gmail.com9158592177

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026